These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 16806434)
1. Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancer. Pinkawa M; Fischedick K; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ Urology; 2006 Jul; 68(1):104-9. PubMed ID: 16806434 [TBL] [Abstract][Full Text] [Related]
2. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy. Hinerman-Mulroy A; Merrick GS; Butler WM; Wallner KE; Allen Z; Adamovich E Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1367-82. PubMed ID: 15275722 [TBL] [Abstract][Full Text] [Related]
4. Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy. Dosoretz AM; Chen MH; Salenius SA; Ross RH; Dosoretz DE; Katin MJ; Mantz C; Nakfoor BM; D'Amico AV Cancer; 2010 Feb; 116(4):837-42. PubMed ID: 20052734 [TBL] [Abstract][Full Text] [Related]
5. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study. Namiki S; Satoh T; Baba S; Ishiyama H; Hayakawa K; Saito S; Arai Y Urology; 2006 Dec; 68(6):1230-6. PubMed ID: 17141839 [TBL] [Abstract][Full Text] [Related]
6. No long-term effects of hormonal therapy preceding brachytherapy on urinary function and health-related quality of life among prostate cancer patients. Evers J; Kupper N; Kessing D; Davits R; Engelen A; Poortmans P; Mols F Urology; 2010 Nov; 76(5):1150-6. PubMed ID: 20869105 [TBL] [Abstract][Full Text] [Related]
7. Impact of hormonal therapy prior to radical prostatectomy on the recovery of quality of life. Namiki S; Saito S; Tochigi T; Kuwahara M; Ioritani N; Yoshimura K; Terai A; Koinuma N; Arai Y Int J Urol; 2005 Feb; 12(2):173-81. PubMed ID: 15733112 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer. Hollenbeck BK; Wei JT; Sanda MG; Dunn RL; Sandler HM Urology; 2004 May; 63(5):946-50. PubMed ID: 15134986 [TBL] [Abstract][Full Text] [Related]
9. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results. Borchers H; Kirschner-Hermanns R; Brehmer B; Tietze L; Reineke T; Pinkawa M; Eble MJ; Jakse G BJU Int; 2004 Oct; 94(6):805-11. PubMed ID: 15476513 [TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer--a matched-pair comparison. Pinkawa M; Asadpour B; Piroth MD; Gagel B; Nussen S; Kehl M; Borchers H; Jakse G; Eble MJ Radiother Oncol; 2009 May; 91(2):225-31. PubMed ID: 19081154 [TBL] [Abstract][Full Text] [Related]
11. Cross-sectional survey of long-term quality of life after radical perineal prostatectomy. Yang BK; Crisci A; Young MD; Silverstein AD; Peterson BL; Dahm P Urology; 2005 Jan; 65(1):120-5. PubMed ID: 15667876 [TBL] [Abstract][Full Text] [Related]
12. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life. Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578 [TBL] [Abstract][Full Text] [Related]
13. Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy. Miller NL; Bissonette EA; Bahnson R; Wilson J; Theodorescu D Cancer; 2003 Mar; 97(5):1203-10. PubMed ID: 12599226 [TBL] [Abstract][Full Text] [Related]
14. The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy. Merrick GS; Butler WM; Wallner KE; Murray B; Allen Z; Lief JH; Galbreath RW Brachytherapy; 2004; 3(1):22-9. PubMed ID: 15110310 [TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen kinetics after brachytherapy or external beam radiotherapy and neoadjuvant hormonal therapy. Pinkawa M; Fischedick K; Piroth MD; Gagel B; Borchers H; Jakse G; Eble MJ Urology; 2007 Jan; 69(1):129-33. PubMed ID: 17270634 [TBL] [Abstract][Full Text] [Related]
16. Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy? Stone NN; Marshall DT; Stone JJ; Cesaretti JA; Stock RG J Urol; 2010 Feb; 183(2):634-9. PubMed ID: 20018308 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE. Speight JL; Elkin EP; Pasta DJ; Silva S; Lubeck DP; Carroll PR; Litwin MS Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1066-75. PubMed ID: 15519776 [TBL] [Abstract][Full Text] [Related]
18. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305 [TBL] [Abstract][Full Text] [Related]
19. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life. Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118 [TBL] [Abstract][Full Text] [Related]
20. Effects of neoadjuvant hormonal therapy on prostate biopsy results after (125)I and (103)Pd seed implantation. Stone NN; Stock RG; Unger P Mol Urol; 2000; 4(3):163-8;discussion 169-70. PubMed ID: 11062370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]